Furthermore, an appreciation of RCC as an immunogenic tumor emerged from the antitumor activity of cytokines such as interleukin 2 (IL-2) [10] and interferon alfa (IFNα) [11], [12], as well as the observation of spontaneous resolution of metastatic disease after removal of the primary RCC [13]. This evidence concerns the gene IL2 and renal cell carcinoma.